JAKARTA, Indonesia, April 28, 2025 /PRNewswire/ — As required by Section 203.01 of the New York Stock Exchange Listed Company Manual, Telkom Indonesia (IDX: TLKM) (NYSE: TLK) confirms that it has filed its annual report on Form 20-F for the year 2024 with the U.S. Securities and Exchange Commission.

Telkom Indonesia’s 20-F report is available on its website at www.telkom.co.id (http://www.telkom.co.id/) as well as through the SEC website at www.sec.gov (http://www.sec.gov/). 

Holders of Telkom Indonesia’s securities can receive a hard copy of the 20-F report (including the complete audited financial statements) free of charge upon request. Requests can be made by contacting Telkom Indonesia Investor Relations at investor@telkom.co.id (mailto:investor@telkom.co.id).

For further information please contact:

PT Telkom Indonesia (Persero) Tbk
Investor Relations
E-mail: investor@telkom.co.id (mailto:investor@telkom.co.id) 
Website: www.telkom.co.id (http://www.telkom.co.id/) 

View original content:https://www.prnewswire.com/news-releases/pt-telkom-indonesia-persero-tbk-2024-annual-report-on-form-20-f-302439967.html

SOURCE PT Telkom Indonesia (Persero) Tbk

ST. PETERSBURG, Fla., April 28, 2025 /PRNewswire/ — ARK Invest is pleased to announce that the ARK Venture Fund (ARKVX), an actively managed interval fund investing in private and public companies at the forefront of disruptive innovation, is now available to advisors who clear or custody through Schwab. This expansion marks another milestone in ARK’s mission to broaden access to venture capital by offering broader access to an asset class that traditionally has been exclusive.

The ARK Venture Fund provides investors with exposure to a curated portfolio of innovative companies spanning industries such as artificial intelligence, reusable rockets, precision therapies, and next-generation cloud technologies. Notable holdings include private companies like SpaceX, OpenAI, and Anthropic, alongside public disruptors such as Tesla and Coinbase.

Cathie Wood, Founder, CEO, and CIO of ARK Invest, stated: “The ARK Venture Fund embodies our commitment to democratizing access to innovation. By expanding availability through Schwab, we’re empowering more advisors and their clients to participate in the growth of disruptive technologies reshaping our world.” In addition to Schwab, the ARK Venture Fund is also accessible through the SoFi and Titan platforms, making it easier than ever for investors to gain exposure to pre-IPO companies alongside public market disruptors. Whether you’re an advisor seeking innovative solutions for your clients or an individual investor looking to diversify your portfolio, the ARK Venture Fund offers a unique opportunity to invest in the future of innovation.

For more information about the ARK Venture Fund and how to invest, visit https://www.ark-funds.com/funds/arkvx.     

About ARK Invest
ARK Investment Management LLC (“ARK Invest” or “ARK”) is a federally registered investment adviser and privately held investment firm. Specializing in thematic investing in disruptive innovation, the firm is rooted in over 40 years of experience in identifying and investing in innovations that should change the way the world works. Through its open research process, ARK identifies companies that it believes are leading and benefiting from cross-sector innovations such as robotics, energy storage, multiomic sequencing, artificial intelligence, and blockchain technology. ARK’s investment strategies include Autonomous Technology and Robotics, Next Generation Internet, Genomic Revolution, Fintech Innovation, Space Exploration & Innovation, 3D Printing, Israel Innovative Technology, the overall ARK Disruptive Innovation Strategy, and the ARK Venture Fund.

For additional information regarding ARK’s funds, please visit http://www.ark-funds.com.

For more information regarding ARK’s research and advisor services, please visit http://www.ark-invest.com.

Distributor: Foreside Fund Services, LLC

Important Information

Before investing you should carefully consider the fund’s investment objectives, risks, charges and expenses. This and other information is in the prospectus, a copy of which may be obtained here. Please read the prospectus carefully before you invest.

An indication of interest in response to this advertisement will involve no obligation or commitment of any kind. 

The ARK Venture Fund invests in private, early-stage companies that may be considered highly speculative. As a result, an investment in the Fund involves substantial risks including risks associated with uncertainty regarding the valuations of private company investments, high rate of failure among the early-stage companies, and restricted liquidity in securities of such companies.

The ARK Venture Fund will be distributed to RIAs, family offices, high net worth individuals and institutional investors through other distribution channels, but is available to retail investors on Titan and SoFi. Titan Global Capital Management USA LLC (“Titan”) is an investment adviser registered with the Securities and Exchange Commission (“SEC”). The fund is offered through SoFi Invest. SoFi Invest refers to the three investment and trading platforms operated by Social Finance, Inc. and its affiliates, SoFi Wealth LLC, an SEC-Registered Investment Adviser (“Sofi Wealth”) and SoFi Securities LLC, Member FINRA/SIPC, (“Sofi Securities). ARK is not affiliated with Titan or any SoFi entity.

The ARK Venture Fund is a continuously-offered, non-diversified, registered closed-end fund with limited liquidity. You should not expect to be able to sell your Shares in the ARK Venture Fund other than through the Fund’s repurchase policy, regardless of how the Fund performs. The Fund’s Shares will not be listed on any securities exchange, and the Fund does not expect a secondary market in the Shares to develop.

ARK Investment Management has entered into an agreement with Titan, where it pays a fee to Titan for the ARK Venture Fund (the “Fund”) to be made available on its platform. In addition, Foreside Fund Services LLC, the distributor of the Fund, may pay Titan a portion of the distribution and services fee it receives from the Fund. ARK Investment Management, Foreside Fund Services, and Titan are unrelated parties.

There is no assurance that the Fund will meet its investment objective. The value of your investment in the Fund, as well as the amount of return you receive on your investment in the Fund, may fluctuate significantly. You may lose part or all of your investment in the Fund or your investment may not perform as well as other similar investments. Therefore, you should consider carefully the following risks before investing in the Fund.

ARK Investment Management LLC is the investment adviser to the ARK Venture Fund.

Contact: Shaina Lamb, 517-652-1296, shaina@dlpr.com

View original content:https://www.prnewswire.com/news-releases/ark-invest-expands-access-to-the-ark-venture-fund-through-schwab-302439972.html

SOURCE ARK Investment Management

BOSTON, April 28, 2025 /PRNewswire/ — Healthy.io is excited to announce that it has just signed an agreement to acquire Labrador Health, a startup that has developed a breakthrough technology for quantitative home testing.

This strategic acquisition marks a step forward in Healthy.io’s mission of transforming home-based diagnostics with lab-quality accuracy, powered by the smartphone. By integrating Labrador Health’s technology with Healthy.io’s FDA-cleared and CE-marked suite of products already available globally, the company is poised to launch the next generation of quantitative at-home kidney testing, expanding access to high-quality diagnostics around the world.

The team is already collaborating on developing the first ever quantitative, home-based ACR test – expected to launch in 2026. This home test is designed to tackle the significant global care-gap in Chronic Kidney Disease. With its novel quantitative features, the product will align with existing care-pathways and international reimbursement schemes, while making testing more accessible and routine – enabling earlier detection and better outcomes at scale.

As part of the integration, all Labrador team members will be joining Healthy.io. At the same time, the company is sharpening its focus on scalable, high-impact offerings by realigning internal resources to accelerate commercialization and innovation in its core markets. This renewed focus will support continued growth of Healthy.io’s existing semi-quantitative product while driving the development of next-generation diagnostics enabled by the newly acquired technology.

“This acquisition is about accelerating our mission to deliver clinical-grade testing from the comfort of home,” said Geoffrey Martin, CEO of Healthy.io. “We’re excited to welcome the Labrador team and to build on our shared commitment to improving kidney care.”

“With just $5 million in funding and a small team, we achieved significant technological milestones,” said Yoav Kessler, CEO of Labrador Health. “We knew that partnering with Healthy.io would be the key to taking our innovation to the next level, combining our breakthrough with their scale and expertise to make a truly global impact.”

Addressing the Growing Need for Early Kidney Disease Detection in the U.S.

Chronic Kidney Disease (CKD) affects over 35 million Americans, yet millions remain undiagnosed. Traditional testing methods often limit access and adherence, especially in at-risk communities. Healthy.io’s at-home semi-quantitative tests have already proven effective in improving access and early detection. The addition of Labrador’s quantitative technology offers even greater clinical insight and empowers better disease management.

A New Chapter in Home-Based Diagnostics

This combination represents a step-change in the accessibility and quality of at-home testing. By uniting Labrador’s innovation with Healthy.io’s computer vision technologies  and operational scale, the companies are poised to redefine how kidney health is monitored and managed—bringing precise, proactive care directly into the hands of patients worldwide.

About Healthy.io

Healthy.io transforms smartphone cameras into clinical-grade diagnostic tools. Its solutions support at-home testing for chronic kidney disease, urinary tract infections, and wound care, reducing barriers to care and driving meaningful health outcomes. Healthy.io partners with leading health systems and retailers across the U.S. and Europe.

About Labrador Health

Labrador Health developed a cutting-edge platform for quantitative urine testing, combining proprietary biochemistry and microfluidics,  and computer vision technologies to deliver lab-grade results at home. The company has partnered with leading clinical institutions to validate its solution, and its technology has received strong interest from both the clinical and investor communities. Founded in 2021 by Yoav Kessler, PhD, and repeat entrepreneur and investor Amit Avner, Labrador has raised $5 million in Seed funding. Investors include Vast Ventures, Box Group, Kli Capital, and prominent angels such as Zach Weinberg and Nat Turner (co-founders of Flatiron Health), Zach Perret and William Hockey (co-founders of Plaid), Logan Green (co-founder of Lyft), and Vivek Garipalli (founder of Clover Health).

Contact: info@healthy.io

Logo: https://mma.prnewswire.com/media/1856865/5290503/Healthy_io_Logo.jpg

View original content to download multimedia:https://www.prnewswire.com/news-releases/healthyio-acquires-labrador-health-advancing-the-future-of-at-home-kidney-diagnostics-302439978.html

SOURCE Healthy.io